Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2005 2
2006 3
2007 8
2008 6
2009 4
2010 8
2011 9
2012 5
2013 2
2014 5
2015 3
2016 3
2017 2
2018 7
2019 10
2020 3
2021 9
2022 10
2023 9
2024 8
2025 4
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
Perl AE, Martinelli G, Cortes JE, Neubauer A, Berman E, Paolini S, Montesinos P, Baer MR, Larson RA, Ustun C, Fabbiano F, Erba HP, Di Stasi A, Stuart R, Olin R, Kasner M, Ciceri F, Chou WC, Podoltsev N, Recher C, Yokoyama H, Hosono N, Yoon SS, Lee JH, Pardee T, Fathi AT, Liu C, Hasabou N, Liu X, Bahceci E, Levis MJ. Perl AE, et al. Among authors: paolini s. N Engl J Med. 2019 Oct 31;381(18):1728-1740. doi: 10.1056/NEJMoa1902688. N Engl J Med. 2019. PMID: 31665578 Clinical Trial.
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
Platzbecker U, Della Porta MG, Santini V, Zeidan AM, Komrokji RS, Shortt J, Valcarcel D, Jonasova A, Dimicoli-Salazar S, Tiong IS, Lin CC, Li J, Zhang J, Giuseppi AC, Kreitz S, Pozharskaya V, Keeperman KL, Rose S, Shetty JK, Hayati S, Vodala S, Prebet T, Degulys A, Paolini S, Cluzeau T, Fenaux P, Garcia-Manero G. Platzbecker U, et al. Among authors: paolini s. Lancet. 2023 Jul 29;402(10399):373-385. doi: 10.1016/S0140-6736(23)00874-7. Epub 2023 Jun 10. Lancet. 2023. PMID: 37311468 Clinical Trial.
Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial.
Della Porta MG, Garcia-Manero G, Santini V, Zeidan AM, Komrokji RS, Shortt J, Valcárcel D, Jonasova A, Dimicoli-Salazar S, Tiong IS, Lin CC, Li J, Zhang J, Pilot R, Kreitz S, Pozharskaya V, Keeperman KL, Rose S, Prebet T, Lai Y, Degulys A, Paolini S, Cluzeau T, Fenaux P, Platzbecker U. Della Porta MG, et al. Among authors: paolini s. Lancet Haematol. 2024 Sep;11(9):e646-e658. doi: 10.1016/S2352-3026(24)00203-5. Epub 2024 Jul 19. Lancet Haematol. 2024. PMID: 39038479 Clinical Trial.
10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial.
Lübbert M, Wijermans PW, Kicinski M, Chantepie S, Van der Velden WJFM, Noppeney R, Griškevičius L, Neubauer A, Crysandt M, Vrhovac R, Luppi M, Fuhrmann S, Audisio E, Candoni A, Legrand O, Foà R, Gaidano G, van Lammeren-Venema D, Posthuma EFM, Hoogendoorn M, Giraut A, Stevens-Kroef M, Jansen JH, de Graaf AO, Efficace F, Ammatuna E, Vilque JP, Wäsch R, Becker H, Blijlevens N, Dührsen U, Baron F, Suciu S, Amadori S, Venditti A, Huls G; EORTC Leukemia Group, GIMEMA, and German MDS Study Group. Lübbert M, et al. Lancet Haematol. 2023 Nov;10(11):e879-e889. doi: 10.1016/S2352-3026(23)00273-9. Lancet Haematol. 2023. PMID: 37914482 Free article. Clinical Trial.
Acute Myeloid Leukemia Mutations: Therapeutic Implications.
Papayannidis C, Sartor C, Marconi G, Fontana MC, Nanni J, Cristiano G, Parisi S, Paolini S, Curti A. Papayannidis C, et al. Among authors: paolini s. Int J Mol Sci. 2019 Jun 3;20(11):2721. doi: 10.3390/ijms20112721. Int J Mol Sci. 2019. PMID: 31163594 Free PMC article. Review.
Signaling pathways and bone marrow microenvironment in myelodysplastic neoplasms.
Ceneri E, De Stefano A, Casalin I, Finelli C, Curti A, Paolini S, Parisi S, Ardizzoia F, Cristiano G, Boultwood J, McCubrey JA, Suh PG, Ramazzotti G, Fiume R, Ratti S, Manzoli L, Cocco L, Follo MY. Ceneri E, et al. Among authors: paolini s. Adv Biol Regul. 2025 Jan;95:101071. doi: 10.1016/j.jbior.2024.101071. Epub 2024 Dec 4. Adv Biol Regul. 2025. PMID: 39648082 Free article. Review.
Conditioning regimens in acute myeloid leukemia.
Visani G, Malagola M, Guiducci B, Lucesole M, Loscocco F, Gabucci E, Paolini S, Piccaluga PP, Isidori A. Visani G, et al. Among authors: paolini s. Expert Rev Hematol. 2014 Aug;7(4):465-79. doi: 10.1586/17474086.2014.939066. Expert Rev Hematol. 2014. PMID: 25025371 Review.
Pathobiology of acute lymphoblastic leukemia.
Paolini S, Gazzola A, Sabattini E, Bacci F, Pileri S, Piccaluga PP. Paolini S, et al. Semin Diagn Pathol. 2011 May;28(2):124-34. doi: 10.1053/j.semdp.2011.02.008. Semin Diagn Pathol. 2011. PMID: 21842698 Review.
Unmet Needs and Their Impact on Quality of Life and Symptoms in Myelodysplastic Neoplasm Patients and Caregivers.
Crisà E, Cilloni D, Riva M, Balleari E, Barraco D, Manghisi B, Borin L, Calmasini M, Calvisi A, Capodanno I, Della Porta MG, Diral E, Fattizzo B, Fenu S, Paolini S, Finelli C, Fozza C, Frairia C, Giai V, Turrini M, Isoni MA, Itri F, Maurillo L, Molteni A, Palumbo GA, Pelizzari AM, Pilo F, Poloni A, Bosi C, Sanpaolo G, Sancetta R, Amato C, Santini V, Voso MT, Salek S, Ionova T, Nosari A, Oliva EN. Crisà E, et al. Among authors: paolini s. Cancers (Basel). 2025 May 7;17(9):1587. doi: 10.3390/cancers17091587. Cancers (Basel). 2025. PMID: 40361511 Free PMC article.
Psychological well-being in Europe after the outbreak of war in Ukraine.
Scharbert J, Humberg S, Kroencke L, Reiter T, Sakel S, Ter Horst J, Utesch K, Gosling SD, Harari G, Matz SC, Schoedel R, Stachl C, Aguilar NMA, Amante D, Aquino SD, Bastias F, Bornamanesh A, Bracegirdle C, Campos LAM, Chauvin B, Coetzee N, Dorfman A, Dos Santos M, El-Haddad RW, Fajkowska M, Göncü-Köse A, Gnisci A, Hadjisolomou S, Hale WW 3rd, Katzir M, Khechuashvili L, Kirchner-Häusler A, Kotzur PF, Kritzler S, Lu JG, Machado GDS, Martskvishvili K, Mottola F, Obschonka M, Paolini S, Perugini M, Rohmer O, Saeedian Y, Sergi I, Shani M, Skimina E, Smillie LD, Talaifar S, Talhelm T, Tokat T, Torres A, Torres CV, Van Assche J, Wei L, Yalçın A, van Zalk M, Bühner M, Back MD. Scharbert J, et al. Among authors: paolini s. Nat Commun. 2024 Feb 20;15(1):1202. doi: 10.1038/s41467-024-44693-6. Nat Commun. 2024. PMID: 38378761 Free PMC article.
110 results